2D materials-based devices and systems for biomedical applications (RIA)

Closed

Programme Category

EU Competitive Programmes

Programme Name

Horizon Europe (2021-2027)

Programme Description

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Details

Identifier Code

HORIZON-CL4-2022-DIGITAL-EMERGING-02-19

Call

2D materials-based devices and systems for biomedical applications (RIA)

Summary

Proposal results are expected to contribute to new technology solutions exploiting the unique properties of 2D materials (2DM) that would reduce cost and increase the efficacy of diagnostics or therapies, or provide new diagnostics or therapies for which there is currently no solution. It would strengthen Europe’s industrial position in, early diagnostics, disease prediction and prevention, disease monitoring and reducing hospitalization time.

Detailed Call Description

Proposals should build on the multi-functionality allowed by 2DMs and demonstrate the advantages of combining e.g. biocompatibility, chemical stability, (bio-)sensing and actuating, and integration with flexible electronic technologies, in addition to versatile surface chemistry (for interface with biology) to allow continuous health monitoring and built-in pharmacological interventions.

The proposals should bring together multidisciplinary teams including engineers, material scientists, pharmacologists, biologists, clinicians, patients, and ethics experts.

Potential application areas include:

  • engineering & bioengineering of biochemical or bioelectronic diagnostics or therapeutic devices and platforms
  • sensors for digital health
  • electronics for brain-computer interfaces, taking advantage of flexible devices
  • medical imaging in combination with implantable devices (e.g. MRI)
  • graphene for drug delivery of therapeutics (e.g. for neurological disorders).

The safety aspects of the proposed technologies should be given proper consideration.

Call Total Budget

€6,00 million

Financing percentage by EU or other bodies / Level of Subsidy or Loan

100%

EU contribution per project:  €6,00 million

Thematic Categories

  • Health
  • Industry
  • Research, Technological Development and Innovation

Eligibility for Participation

  • Large Enterprises
  • Other Beneficiaries
  • Private Bodies
  • Researchers/Research Centers/Institutions
  • State-owned Enterprises

Call Opening Date

16/06/2022

Call Closing Date

16/11/2022

National Contact Point(s)

Research and Innovation Foundation

29a Andrea Michalakopoulou Street, 1075 Nicosia
T.Th. 23422, 1683 Nicosia
+357 22205000
Email: support@research.org.cy

Dr Angelos Ntantos
Scientific Officer
Telephone: 35722205033
Email: antantos@research.org.cy

Dr Ioannis Theodorou

Scientific Officer
Telephone: 35722205038
Email: itheodorou@research.org.cy

(Publish Date: 14/02/2022-for internal use only)

EU Contact Point

Εuropean Commission, Directorate-General for Research and Innovation

https://ec.europa.eu/info/departments/research-and-innovation_en#contact